Toxic Cardiomyopathy or Drug-Induced Cardiotoxicity
The medical term for heart failure caused by ingestion of a toxic substance or concoction is "toxic cardiomyopathy" or "drug-induced cardiotoxicity." When specifically referring to heart failure resulting from substance ingestion, the broader umbrella term is cardiotoxicity, which encompasses the spectrum of cardiac damage from toxic exposures 1, 2.
Understanding the Terminology
The term "cardiotoxicity" is a broad descriptor that refers to the negative effects of toxic substances on the heart 3. This encompasses:
- Heart failure (the most common serious manifestation)
- Cardiomyopathy (structural heart muscle disease)
- Myocardial ischemia
- Arrhythmias
- Myocarditis
- Conduction abnormalities
When the toxic exposure leads specifically to heart failure with structural changes, the precise term is "toxic cardiomyopathy" or "drug-induced cardiomyopathy" 4.
Context-Specific Terms
The nomenclature varies based on the causative agent:
For Pharmaceutical Agents
- Drug-induced cardiotoxicity is the standard term when prescription or over-the-counter medications cause cardiac damage 2, 5
- Examples include anthracycline-induced cardiotoxicity (AIC) from chemotherapy agents like doxorubicin 4
For Illicit Substances
- Substance-induced cardiomyopathy when referring to drugs like cocaine or alcohol 3, 6
- Alcohol specifically causes alcoholic cardiomyopathy through oxidative stress and apoptosis 3
For Environmental Toxins
- Toxic cardiomyopathy when caused by environmental poisons, pesticides, heavy metals (cadmium), or other exotoxins 6
Clinical Relevance
The distinction matters for treatment and prognosis. Drug-induced cardiotoxicity often improves with discontinuation of the offending agent, while some forms (particularly anthracycline-induced) may be irreversible and progressive 4. The mechanism typically involves:
- Mitochondrial dysfunction 6
- Free radical formation 4
- Apoptosis (programmed cell death) 4, 3
- Direct myocardial toxicity 1
Documentation Considerations
When documenting in medical records, specify:
- The exact causative agent when known
- Whether it's acute versus chronic presentation
- The specific cardiac manifestation (heart failure, arrhythmia, etc.)
For example: "Acute heart failure secondary to doxorubicin-induced cardiotoxicity" is more precise than simply "toxic cardiomyopathy" 4.